Docusign Inc (NASDAQ:DOCU) Shares Acquired by Hamilton Lane Advisors LLC

Share on StockTwits

Hamilton Lane Advisors LLC boosted its holdings in shares of Docusign Inc (NASDAQ:DOCU) by 32.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,294 shares of the company’s stock after purchasing an additional 3,761 shares during the period. Docusign makes up approximately 1.6% of Hamilton Lane Advisors LLC’s holdings, making the stock its 15th biggest position. Hamilton Lane Advisors LLC’s holdings in Docusign were worth $3,292,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in DOCU. Toth Financial Advisory Corp lifted its position in shares of Docusign by 222.2% in the 2nd quarter. Toth Financial Advisory Corp now owns 145 shares of the company’s stock valued at $25,000 after acquiring an additional 100 shares in the last quarter. Kore Private Wealth LLC purchased a new stake in shares of Docusign in the 2nd quarter valued at approximately $25,000. Creative Financial Designs Inc. ADV purchased a new stake in shares of Docusign in the 2nd quarter valued at approximately $26,000. WASHINGTON TRUST Co purchased a new stake in shares of Docusign in the 2nd quarter valued at approximately $27,000. Finally, Nvwm LLC purchased a new stake in shares of Docusign in the 2nd quarter valued at approximately $28,000. 76.87% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ DOCU traded down $5.85 during trading hours on Friday, hitting $234.60. 2,557,603 shares of the stock were exchanged, compared to its average volume of 4,427,345. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.13 and a quick ratio of 1.13. The company’s 50 day moving average is $216.51 and its 200 day moving average is $169.83. The firm has a market capitalization of $43.44 billion, a P/E ratio of -207.61 and a beta of 0.90. Docusign Inc has a one year low of $61.68 and a one year high of $290.23.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, September 3rd. The company reported $0.17 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.21) by $0.38. The business had revenue of $342.21 million during the quarter, compared to the consensus estimate of $318.55 million. Docusign had a negative net margin of 17.74% and a negative return on equity of 28.28%. Docusign’s quarterly revenue was up 45.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.01 EPS. Research analysts anticipate that Docusign Inc will post -0.9 earnings per share for the current fiscal year.

In other Docusign news, Director Enrique T. Salem sold 15,000 shares of the stock in a transaction on Tuesday, September 29th. The shares were sold at an average price of $214.35, for a total value of $3,215,250.00. Following the completion of the sale, the director now directly owns 158,593 shares of the company’s stock, valued at approximately $33,994,409.55. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Enrique T. Salem sold 49,299 shares of the stock in a transaction on Friday, September 18th. The shares were sold at an average price of $191.78, for a total transaction of $9,454,562.22. Following the completion of the sale, the director now directly owns 166,093 shares of the company’s stock, valued at $31,853,315.54. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 111,698 shares of company stock valued at $22,229,708. 5.06% of the stock is owned by insiders.

Several equities research analysts recently commented on the stock. JMP Securities upped their price target on shares of Docusign from $233.00 to $261.00 and gave the company an “outperform” rating in a research report on Friday, September 4th. Evercore ISI upped their price objective on shares of Docusign from $210.00 to $250.00 in a research note on Friday, September 4th. Oppenheimer upped their price objective on shares of Docusign from $200.00 to $300.00 and gave the company an “outperform” rating in a research note on Wednesday, September 2nd. Piper Sandler upped their price objective on shares of Docusign from $140.00 to $235.00 in a research note on Friday, September 4th. Finally, DA Davidson upped their price objective on shares of Docusign from $161.00 to $270.00 in a research note on Friday, September 4th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $226.65.

Docusign Profile

DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.

Recommended Story: Learning About the VIX – Volatility Index

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc (NASDAQ:DOCU).

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.